Genmab A/S (GMAB)

Genmab Stock Forecast

Stock Price Forecast

The 5 analysts that cover Genmab stock have a consensus rating of "Buy" and an average price target of $37.6, which forecasts a 35.62% increase in the stock price over the next year. The lowest target is $27 and the highest is $48.

Price Target: $37.6 (+35.62%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$27	$37.6	$36	$48
Change	-2.61%	+35.62%	+29.85%	+73.13%

Analyst Ratings

The average analyst rating for Genmab stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	3	3	3	2	2	2
Buy	4	4	4	4	3	3
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	8	7	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $35 → $36	Strong Buy	Maintains	$35 → $36	+29.85%	Aug 15, 2025
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Maintains $45 → $46	Strong Buy	Maintains	$45 → $46	+65.92%	Jul 8, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $50 → $37	Strong Buy	Reiterates	$50 → $37	+33.45%	Apr 9, 2025
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Maintains $50 → $45	Strong Buy	Maintains	$50 → $45	+62.31%	Mar 11, 2025
Matt Phipps William Blair	William Blair	Hold → Buy Upgrades n/a	Hold → Buy	Upgrades	n/a	n/a	Mar 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.67B

Increased by 22.68%

from 2.99B

Revenue Next Year

4.25B

Increased by 15.85%

from 3.67B

EPS This Year

15.95

Decreased by -5.34%

from 16.85

EPS Next Year

18.89

Increased by 18.45%

from 15.95

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.66B	1.29B	2.08B	2.44B	2.99B	3.67B	4.25B
Revenue Growth	106.20%	-22.52%	61.88%	17.23%	22.32%	22.68%	15.85%
EPS	11.87	6.85	11.87	9.79	16.85	15.95	18.89
EPS Growth	132.20%	-42.30%	73.29%	-17.49%	72.08%	-5.34%	18.45%
Forward PE	-	-	-	-	-	1.74	1.47
No. Analysts	-	-	-	-	-	24	24

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	4.1B	4.8B
Avg	3.7B	4.2B
Low	3.3B	3.7B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	36.3%	31.8%
Avg	22.7%	15.8%
Low	11.1%	-0.3%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	19.83	26.29
Avg	15.95	18.89
Low	12.01	11.96

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	17.7%	64.9%
Avg	-5.3%	18.5%
Low	-28.7%	-25.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.